Pharmaceutical Business review

Geisinger Health selects Carestream’s optical molecular imaging technology

The objective of this research is to make surgery for brain tumors and inflammatory lesions simpler and more precise by using fluorescent nanospheres to more easily visualize tumors and lesions during treatment procedures, said Carestream Health.

Geisinger’s neuroscience lab chose the company’s Kodak in-vivo multispectral imaging system FX to assess which nanoparticles would be most efficacious for image-guided brain surgery in patients in the near future.